Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Percutaneous transfemoral management of severe secondary tricuspid regurgitation with Edwards Sapien XT bioprosthesis: first-in-man experience.

Laule M, Stangl V, Sanad W, Lembcke A, Baumann G, Stangl K.

J Am Coll Cardiol. 2013 May 7;61(18):1929-31. doi: 10.1016/j.jacc.2013.01.070. No abstract available.

2.

Transcatheter tricuspid valve implantation by femoral approach in trivalvular heart disease.

Ribichini F, Pesarini G, Feola M, Agostini M, Molinari G, Rossi A, Faggian G, Vassanelli C.

Am J Cardiol. 2013 Oct 1;112(7):1051-3. doi: 10.1016/j.amjcard.2013.05.043.

PMID:
23910430
3.

Transfemoral access for valve in valve implantation of an Edwards Sapien XT valve in a stenotic tricuspid bioprosthesis under fluoroscopic guidance.

Greif M, Schramm R, Steinbeck G, Hagl C, Schmitz C, Kupatt C.

Can J Cardiol. 2013 Aug;29(8):1014.e3-4. doi: 10.1016/j.cjca.2012.11.027.

PMID:
23406738
4.

Jailing of a Pacemaker Lead During Tricuspid Valve-in-Valve Implantation With an Edwards SAPIEN XT Transcatheter Heart Valve.

Paradis JM, Bernier M, Houde C, Dumont É, Doyle D, Mohammadi S, DeLarochellière R, Philippon F, Rodés-Cabau J.

Can J Cardiol. 2015 Jun;31(6):819.e9-11. doi: 10.1016/j.cjca.2015.01.037. No abstract available.

PMID:
25935882
5.

Management of tricuspid regurgitation by caval valve implantation: from technical feasibility to evaluation of efficacy.

Lauten A, Hamadanchi A, Doenst T, Figulla HR.

J Am Coll Cardiol. 2013 Dec 10;62(23):2258-9. doi: 10.1016/j.jacc.2013.05.101. No abstract available.

6.

Reply: management of tricuspid regurgitation by caval valve implantation: from technical feasibility to evaluation of efficacy.

Laule M, Stangl V, Baumann G, Stangl K.

J Am Coll Cardiol. 2013 Dec 10;62(23):2259. doi: 10.1016/j.jacc.2013.07.092. No abstract available.

7.

Successful transfemoral Edwards SAPIEN 3 valve in valve implantation in a patient with a degenerated aortic bioprosthesis associated with severe paravalvular aortic regurgitation.

Bijuklic K, Hansen L, Witt J, Schofer J.

Clin Res Cardiol. 2015 Jan;104(1):92-3. doi: 10.1007/s00392-014-0760-9. No abstract available.

PMID:
25227426
8.

Tricuspid Valve Replacement: A Percutaneous Transfemoral Valve-in-Ring Approach.

Cabasa AS, Eleid MF, Rihal CS, Villarraga HR, Foley TA, Suri RM.

JACC Cardiovasc Interv. 2015 Jul;8(8):1126-8. doi: 10.1016/j.jcin.2015.03.025. No abstract available.

9.

Transcatheter tricuspid valve implantation: a multicentre French study.

Godart F, Baruteau AE, Petit J, Riou JY, Sassolas F, Lusson JR, Fraisse A, Boudjemline Y.

Arch Cardiovasc Dis. 2014 Nov;107(11):583-91. doi: 10.1016/j.acvd.2014.07.051. Review.

10.

First-in-man transfemoral transcatheter aortic valve replacement with the 29 mm Edwards SAPIEN XT valve.

Freeman M, Rodés-Cabau J, Urena M, DeLarochelliere R, Dumont E, Masson JB, Willson AB, Binder RK, Toggweiler S, Leipsic J, Wood DA, Webb JG.

Catheter Cardiovasc Interv. 2013 Oct 1;82(4):664-70. doi: 10.1002/ccd.24543.

PMID:
22744829
11.

Transfemoral implantation of an Edwards SAPIEN valve in a tricuspid bioprosthesis without fluoroscopic landmarks.

Calvert PA, Himbert D, Brochet E, Radu C, Iung B, Hvass U, Darondel JM, Depoix JP, Nataf P, Vahanian A.

EuroIntervention. 2012 Mar;7(11):1336-9. doi: 10.4244/EIJV7I11A209.

12.

First-in-Human Transcatheter Pulmonic Valve Implantation Through a Tricuspid Valve Bioprosthesis to Treat Native Pulmonary Valve Regurgitation Caused by Carcinoid Syndrome.

Kesarwani M, Ports TA, Rao RK, Mahadevan VS.

JACC Cardiovasc Interv. 2015 Aug 24;8(10):e161-3. doi: 10.1016/j.jcin.2015.03.032. No abstract available.

13.

Cracking a tricuspid perimount bioprosthesis to optimize a second transcatheter sapien valve-in-valve placement.

Brown SC, Cools B, Gewillig M.

Catheter Cardiovasc Interv. 2016 Sep;88(3):456-9. doi: 10.1002/ccd.26507.

PMID:
27015096
14.

Percutaneous transjugular implantation of MELODY® valve into tricuspid bioprosthesis.

Bhamidipati CM, Scott Lim D, Ragosta M, Ailawadi G.

J Card Surg. 2013 Jul;28(4):391-3. doi: 10.1111/jocs.12128.

15.

Transfemoral and transseptal valve-in-valve implantation into a failing mitral xenograft with a balloon-expandable biological valve.

Schaefer U, Frerker C, Schewel D, Thielsen T, Meincke F, Kreidel F, Kuck KH.

Ann Thorac Surg. 2012 Dec;94(6):2115-8. doi: 10.1016/j.athoracsur.2012.04.123.

PMID:
23176928
16.

Transfemoral valve-in-ring implantation for a failing mitral homograft in the tricuspid position.

Fassa AA, Himbert D, Brochet E, Labbé JP, Vahanian A.

EuroIntervention. 2014 Jun;10(2):269. doi: 10.4244/EIJV10I2A43. No abstract available.

17.

Transfemoral implantation of transcatheter heart valves after deterioration of mitral bioprosthesis or previous ring annuloplasty.

Bouleti C, Fassa AA, Himbert D, Brochet E, Ducrocq G, Nejjari M, Ghodbane W, Depoix JP, Nataf P, Vahanian A.

JACC Cardiovasc Interv. 2015 Jan;8(1 Pt A):83-91. doi: 10.1016/j.jcin.2014.07.026.

18.

Transcatheter Edwards Sapien XT valve in valve implantation in degenerated aortic bioprostheses via transfemoral access.

Greif M, Lange P, Mair H, Becker C, Schmitz C, Steinbeck G, Kupatt C.

Clin Res Cardiol. 2012 Dec;101(12):993-1001. doi: 10.1007/s00392-012-0488-3.

PMID:
22729757
19.

Transfemoral aortic valve replacement with the Edwards SAPIEN and Edwards SAPIEN XT prosthesis using exclusively local anesthesia and fluoroscopic guidance: feasibility and 30-day outcomes.

Durand E, Borz B, Godin M, Tron C, Litzler PY, Bessou JP, Bejar K, Fraccaro C, Sanchez-Giron C, Dacher JN, Bauer F, Cribier A, Eltchaninoff H.

JACC Cardiovasc Interv. 2012 May;5(5):461-7. doi: 10.1016/j.jcin.2012.01.018.

20.

Echocardiographic images of a melody valve in the tricuspid position.

Khan S, Cheatham JP, Kollins K, Cua CL.

Echocardiography. 2014 Mar;31(3):E98-100. doi: 10.1111/echo.12465. No abstract available.

PMID:
24372796

Supplemental Content

Support Center